Clinical Studies

Clinical studies involving healthy volunteers and patients play a vital role in the development of new drugs. These studies are conducted to ensure that all investigational drugs are safe and effective. Over recent years, along with drug discovery, drug development and clinical studies have benefitted from scientific and technological advancements as well as a greater understanding of the needs clinical study participants have.

At UCB we’ve moved away from seeing patients as just patients. By really listening and engaging with them as partners we are striving for greater understanding of their needs or ways to improve our clinical studies. To improve and accelerate development, we will keep patients’ needs front and center, leverage new technologies, and adaptive clinical study design to improve the patient experience.

We strive for our solutions to provide the best individual experience for patients, and we aim for the participants of our studies to be reflective of the populations that will ultimately benefit from our new medicines. This means encompassing a broader spectrum of the population in clinical trials, ultimately advancing health for all patients and helping us better understand our investigational drugs and make better medicines.

We are committed to working toward a clinical trials infrastructure that promotes clinical trial diversity to better reflect the intended treatment population. We continue our work to identify best practices around key drivers such as scientific rigor, informing innovation, and improving the health of all our patients and communities worldwide.